Skip to main content

Cytiva

MabSelect™ SuRe 70 protein A resin, with high dynamic binding capacity (DBC), enables highly cost-efficient capture of monoclonal antibodies (mAbs).

The resin uses the well-established SuRe protein A ligand with good alkaline stability providing stable processing of mAbs.

  • Cost-efficient at low resin utilization, such as in clinical manufacturing.
  • Highest DBC of any of our MabSelect SuRe™ resins
  • Alkaline-stable, well-established protein A ligand, from the MabSelect SuRe resin, is stable when cleaned with 0.1 M NaOH for 200 cycles and approximately 100 cycles using 0.5 M NaOH.
  • Excellent for use in short bed heights and rapid resin cycling mode to further improve productivity in protein A step.